WAS
CTSO icon

Wealth Advisory Solutions’s Cytosorbents Corp CTSO Stock Holding History

Wealth Advisory Solutions’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-139,100
Closed -$1.2M – 175
2021
Q1 		$1.2M Buy
+139,100
New +$1.33M 0.9% 29

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealth Advisory Solutions's CTSO Position: Q2 2021 in Review

Wealth Advisory Solutions sold out of Cytosorbents Corp (CTSO) in Q2 2021, closing a stake of 139,100 shares — an estimated $1.2M sold.

Wealth Advisory Solutions first reported a position in CTSO in Q1 2021 and held it in 1 quarter. The position peaked at $1.2M in Q1 2021. 102 funds tracked by Wall St. Rank hold CTSO as of Q2 2021.

  • Wealth Advisory Solutions reported no remaining Cytosorbents Corp position as of Q2 2021 after selling out during the quarter.
  • Wealth Advisory Solutions sold 139,100 Cytosorbents Corp shares in Q2 2021, an estimated $1.2M.
  • Wealth Advisory Solutions first reported a position in Cytosorbents Corp in Q1 2021 and held it in 1 quarter.
  • Wealth Advisory Solutions's Cytosorbents Corp position peaked at $1.2M in Q1 2021.
  • 102 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2021.

Based on Wealth Advisory Solutions's 13F filing for Q2 2021, filed 21 Jul 2021.